The historical rank and industry rank for Span-America Medical Systems's EV-to-EBIT or its related term are showing as below:
SPAN's EV-to-EBIT is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 20.215 * Ranked among companies with meaningful EV-to-EBIT only.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Span-America Medical Systems's EV-to-EBIT
For the Medical Devices subindustry, Span-America Medical Systems's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Span-America Medical Systems's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Span-America Medical Systems's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Span-America Medical Systems's EV-to-EBIT falls into.
Span-America Medical Systems EV-to-EBIT Calculation
Span-America Medical Systems's current Enterprise Value is $82.91 Mil.
Span-America Medical Systems's EBIT for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.87 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Span-America Medical Systems (NAS:SPAN) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Span-America Medical Systems's Enterprise Value for the quarter that ended in Mar. 2017 was $52.52 Mil.
Span-America Medical Systems's EBIT for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.87 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Span-America Medical Systems EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Span-America Medical Systems's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Span-America Medical Systems (Span-America Medical Systems) Business Description
Span-America Medical Systems Inc was incorporated under the laws of the state of South Carolina on September 21, 1970. The Company manufactures and distributes therapeutic support surfaces, mattress overlays, patient positioners, seating cushions, skin care products and fall prevention products for the medical market and pillows, mattress pads and various foam products for the custom products market throughout the United States and Canada. Its operations are divided into two main business units or segments: medical and custom products. The Company's main medical products consist of polyurethane foam mattress overlays, therapeutic support surfaces (which consist of non-powered and powered therapeutic support surfaces) and patient positioners as well as Selan (r) skin care, seating and fall protection products. The Company's custom products segment includes two product lines namely consumer bedding products and various engineered industrial products. The Company's consumer product line consists mainly of convoluted and contour-cut mattress overlays and specially designed pillows for the consumer bedding market. It sells these products mainly in North America to customers in the segments of the health care market, including acute care hospitals, long-term care facilities and home health care providers. The Company's manufacturing operations are subject to various government regulations pertaining to the discharge of materials into the environment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SPAN has been successfully added to your 